OCGNVSRARE• 28 Days (Normalized)
OCGN vs RARE (Ocugen Inc. vs Ultragenyx Pharmaceutical Inc.)
Showing Closing Date Range from Aug, 19 to Sep, 16, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
OCGN Performance $0.99
-32.86%
Ocugen Inc.
Normalized Baseline0.00%
RARE Performance $12.99
-50.5%
Ultragenyx Pharmaceutical Inc.
Normalized Baseline0.00%
Alpha Spread Margin OCGN LEADS
+17.64%
OCGN outperforming by 17.64%
OCGNRARE
Spread Trajectory28 Days (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
OCGN RARE
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(20 dates)
| Date | OCGN Price | OCGN Gain (%) | RARE Price | RARE Gain (%) | Spread |
|---|---|---|---|---|---|
| Sep 16, 2026 | $0.99 | -32.86% | $12.99 | -50.50% | +17.64% |
| Sep 15, 2026 | $0.99 | -32.84% | $13.07 | -50.19% | +17.35% |
| Sep 14, 2026 | $1.06 | -28.38% | $13.61 | -48.13% | +19.75% |
| Sep 11, 2026 | $1.02 | -31.08% | $14.30 | -45.50% | +14.42% |
| Sep 10, 2026 | $1.03 | -30.74% | $14.40 | -45.12% | +14.38% |
| Sep 09, 2026 | $1.07 | -28.04% | $14.31 | -45.46% | +17.42% |
| Sep 08, 2026 | $1.33 | -10.14% | $14.88 | -43.29% | +33.15% |
| Sep 04, 2026 | $1.36 | -8.11% | $15.30 | -41.69% | +33.58% |
| Sep 03, 2026 | $1.35 | -8.78% | $14.85 | -43.41% | +34.63% |
| Sep 02, 2026 | $1.32 | -10.81% | $26.53 | +1.11% | -11.92% |
| Sep 01, 2026 | $1.33 | -10.14% | $25.81 | -1.64% | -8.50% |
| Aug 31, 2026 | $1.33 | -10.14% | $25.21 | -3.93% | -6.21% |
| Aug 28, 2026 | $1.32 | -10.81% | $25.61 | -2.40% | -8.41% |
| Aug 27, 2026 | $1.37 | -7.43% | $26.26 | +0.08% | -7.51% |
| Aug 26, 2026 | $1.41 | -4.73% | $26.44 | +0.76% | -5.49% |
Page 1 of 2